Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dentin collagen network refers to the three-dimensional, extracellular meshwork of primarily type I collagen fibrils that forms the organic scaffold of dentin—a key mineralized tissue in teeth located beneath enamel and cementum[1][5][6]. This network is essential for the mechanical stability, resilience, and mineralization of dentin, serving as a template for the deposition of hydroxyapatite crystals and supporting overall tooth structure[5][1][7]. Collagen fibrils in dentin are produced by odontoblasts during tooth development and are stabilized through extensive cross-linking and limited turnover in adult tissues, making them resistant to degradation under normal physiological conditions[1][5]. However, they are susceptible to enzymatic breakdown by endogenous collagenolytic enzymes such as matrix metalloproteinases (MMPs) and cysteine cathepsins, particularly after acid-etching procedures in restorative dentistry, leading to degradation of resin-dentin bonds over time[3]. Protection or reinforcement of the dentin collagen network is an area of active investigation for improving clinical longevity of dental restorations[1][3]. The network is not a druggable target in the classical sense (i.e., it is not a receptor, enzyme, transporter, or similar molecule), but it is a crucial component for tissue health and engineering approaches in dentistry[1].
Drugs such as chlorhexidine or MMP inhibitors act by inhibiting matrix metalloproteinases or cathepsins that degrade the collagen mesh, thus preserving restoration bond strength[3] No classical ligand/receptor pharmacology
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dentin collagen network.